- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Cannvas to Attend Extraordinary Future 2018 Conference in Vancouver, BC
Cannvas MedTech (CSE:MTEC) (“Cannvas” or the “Company”), a leading business technology company in the cannabis space, is pleased to announce that its senior management team will be attending Extraordinary Future 2018 on September 19-20 in Vancouver, BC.
Cannvas MedTech (CSE:MTEC) (“Cannvas” or the “Company”), a leading business technology company in the cannabis space, is pleased to announce that its senior management team will be attending Extraordinary Future 2018 on September 19-20 in Vancouver, BC. Extraordinary Future 2018 is an excellent opportunity to showcase Canadian technologies to the investment community. The Cannvas executive team will be available for meetings in Booth #708 where CEO Shawn Moniz and COO Steve Loutskou will be in attendance. Mr. Moniz will also deliver an investor presentation on September 20th at 12:10 pm.
Event: | Extraordinary Future 2018 |
Date: | Thursday, September 20, 2018 |
Booth: | #708 |
Presentation: | 12:10 – 12:20pm PT, Workshop 1 |
Venue: | Vancouver Convention Centre East, 999 Canada Place, Vancouver, BC |
Event Hours: | 9:00am – 6:00pm |
Produced by Cambridge House International and held at the Vancouver Convention Centre, the two-day conference focuses on innovative technologies and offers attendees the chance to connect with entrepreneurs, investors, and innovators. The theme of the conference is to explore ideas that will directly impact the “the extraordinary future of science and life.” To that end, topics to be discussed include:
- Cannabis Delivery Systems
- Mental Health and Longevity
- Startup Competition
- Battery Technology
- Blockchain & the Music Industry
- Tokenized Securities
- Quantum Computing
- Data Warfare
Extraordinary Future features a tradeshow exhibition, one-on-one meetings with investors, presentations, keynote speakers, and much more.
To register and for more information visit: www.extraordinaryfuture.com.
About Cannvas MedTech Inc.
Cannvas MedTech is a leading business technology company in the cannabis space. We design and build customer-centric solutions that enable our partners to harness the power of data to truly understand their customers, industry, and key business drivers.
For additional information:
www.cannvasmedtech.com
No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.
Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer’s future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties. For a description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Company’s Management’s Discussion and Analysis and other disclosure filings with Canadian securities regulators, which are posted onwww.sedar.com.
For further information: Media Inquiries: media@cannvasmedtech.com; Investor Relations: ir@cannvasmedtech.com, 1-800-489-0116
Click here to connect with Cannvas MedTech (CSE:MTEC) for an Investor Presentation.
Source: www.newswire.ca
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.